TENAX THERAPEUTICS, INC. Cash and Restricted Cash
TENAX THERAPEUTICS, INC. (TENX) had Cash and Restricted Cash of $117.98 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-31
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $117.98M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $118.75M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $97.56M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $99.37M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $117.98M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $118.75M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $97.56M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $99.37M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $105.46M 10-Q · filed 2026-07-31 | |
| 2025-03-31 | $111.45M 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $94.85M 10-Q · filed 2026-07-31 | |
| 2024-09-30 | $98.31M 10-Q · filed 2025-11-12 | $98.31M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $9.38M 10-Q · filed 2025-08-13 | $9.38M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $12.55M 10-Q · filed 2025-05-14 | $12.55M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $9.79M 10-K · filed 2026-03-10 | $9.79M 10-K · filed 2024-03-28 |
| 2023-09-30 | $11.14M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $13.39M 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $14.41M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $2.12M 10-K · filed 2025-03-25 | $2.12M 10-K · filed 2023-03-31 |
| 2022-09-30 | $3.81M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $7.23M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $2.87M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $5.58M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $8.35M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $6.25M 10-K · filed 2023-03-31 | |
| 2019-12-31 | $4.91M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |